Registrieren Sie sich, um Meldungen für Instrumente,
Wirtschaftsevents und Inhalte von Autoren zu erhalten, denen Sie folgen
Kostenlose Registrierung Sie haben bereits ein Benutzerkonto? Anmelden
Kurse
Alle Finanzinstrumente
- Alle Finanzinstrumente
- Indizes
- Aktien
- ETFs
- Fonds
- Rohstoffe
- Währungen
- Krypto
- Anleihen
- Zertifikate
Versuchen Sie es noch einmal mit einem anderen Suchbegriff
👀 👁 🧿 Biogen: +4,56% nach Quartalszahlen. Unsere KI erkannte das Potenzial bereits im März 2024.
Welche Aktie wird als nächstes durchstarten?
Welche Aktie wird als nächstes durchstarten?
Jetzt Aktien finden
Ab - International Health Care Portfolio C Acc (LP65068120)
Einem Portfolio hinzufügen/entfernen
Portfolio hinzufügen
436,360
-1,110
-0,25%
Typ:
Fonds
Markt:
Singapur
Emittent:
AllianceBernstein (Luxembourg) S.à r.l.
ISIN:
LU0310148241
Anlageklasse:
Aktie
- Morningstar Rating:
- Fondsvermögen: 3,96B
AB SICAV I - International Health Care Portfolio C
436,360
-1,110
-0,25%
- Allgemein
- Chart
- Nachrichten & Analysen
- Forum
LP65068120 Übersicht
Auf dieser Seite finden Sie ein ausführliches Ab - International Health Care Portfolio C Acc Profil. Erfahren Sie mehr über das Management, das Gesamtvermögen, die Anlagestrategie und die LP65068120 Kontaktinformationen.
Investmentstrategie
Unter normalen Umständen investiert der Fonds hauptsächlich in Aktien von Unternehmen im Gesundheitssektor und verwandten Branchen. Dabei bevorzugt der Fonds Anlagen in Wertpapiere, die über Potenzial für ein überdurchschnittliches Ertragswachstum verfügen. Zudem kann er in Aktien von Unternehmen weltweit sowie in den Schwellenländern investieren. Im Hinblick auf ein effizientes Portfoliomanagement und die Verringerung potenzieller Risiken kann der Fonds Derivate einsetzen.
Kontaktinformation
Adresse
One International Finance Centre
Hong Kong, L-2453
Hong Kong
Hong Kong, L-2453
Hong Kong
Telefon
+352 46 39 36 151
Web
www.abglobal.com
Management
| Name | Titel | Seit | Bis |
|---|---|---|---|
| John H. Fogarty | Senior Vice President | 2019 | Aktuell |
| Biografie | John Fogarty is a Senior Vice President and Portfolio Manager for U.S. Growth Equities at AB, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the U.S., having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Varden Partners. Mr. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Mr. Fogarty holds a B.A. in history from Columbia University and is a CFA charterholder. | ||
| Vinay Thapar | Senior Vice President | 2013 | Aktuell |
| Biografie | Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York | ||
| John H. Fogarty | Senior Vice President | 2013 | 2018 |
| Biografie | John Fogarty is a Senior Vice President and Portfolio Manager for U.S. Growth Equities at AB, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the U.S., having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Varden Partners. Mr. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Mr. Fogarty holds a B.A. in history from Columbia University and is a CFA charterholder. | ||
| Bryce Hill | - | 2013 | 2015 |
| Biografie | Mr. Hill is portfolio manager for the Disciplined Value strategy. He heads the global Health Care sector team and is a senior research analyst for the firm’s value/core equity strategies focusing on the health care and technology sectors. Mr. Hill is a CFA charterholder and holds an MBA from Columbia University and a BS in Business Administration, summa cum laude, from the University of Southern California. | ||
| Tassos M. Stassopoulos | Senior Vice President | 2011 | 2013 |
| Biografie | Tassos founded Trinetra in 2016 as a small, dedicated investment boutique using ethnographic research to capture growth opportunities in emerging markets. Tassos believes that understanding consumer’s mindsets in their cultural context allows investors to anticipate trends, which not only improves investment outcomes, but also helps people in Emerging Markets to realise their dreams. Prior to that, Tassos was Head of EM Growth Equity at Ashmore which he joined after nine years at AllianceBernstein where he was Portfolio Manager for Emerging Consumer, Global Growth and Thematic equity products. He was previously a Managing Director at Credit Suisse and for six years he was the senior analyst for European travel and leisure, twice ranked number 1 in the Institutional Investor survey. He then spent a year as a Portfolio Manager at the firm’s internal hedge fund, Modal Capital. He also spent eight years as a Chartered Accountant and then as a management consultant at Arthur Andersen. Tassos holds an MA in Economics from Cambridge University and is a Fellow of the Institute of Chartered Accountants. | ||
| Steven Nussbaum | - | 2007 | 2012 |
| Biografie | Dr. Nussbaum manages the AllianceBernstein Healthcare Funds and is also the Healthcare Sector Head for Global Research Growth. Prior to joining Alliance Capital in 2002, Dr. Nussbaum worked as a Medical Products analyst at JP Morgan from 1999-2002. Prior to coming to Wall Street, he was an attending physician and a Clinical Assistant Professor of Radiology at Thomas Jefferson University Hospital in Philadelphia and before that he was an attending physician at Long Island Jewish Medical Center in New York. Dr. Nussbaum completed a radiology fellowship at Thomas Jefferson University Hospital, a radiology residency at Montefiore Medical Center in New York, and a medical internship at Danbury Hospital in Connecticut. He holds a BA from Harvard University, an MD from the Albert Einstein College of Medicine, and an MBA from the NYU Stern School of Business. | ||
| Norman M. Fidel | Senior Vice President | 1995 | 2007 |
| Biografie | Fidel is a senior vice president of AllianceBernstein. He joined the firm from Eberstadt Asset Management, where he served as a senior vice president and the director of research. Prior to that, he was a security analyst with Irving Trust Company. Fidel is a member of the New York Society of Security Analysts and the Health Industries Analyst Group of New York. | ||
Was denken Sie über Ab - International Health Care Portfolio C Acc
Sind Sie sicher, dass Sie diesen Chart löschen möchten?
Löschen Abbrechen
Angehängten Chart durch einen neuen Chart ersetzen?
Ersetzen Abbrechen
Community-Richtlinien
Chart zum Kommentar hinzufügen
Sperre bestätigen
Sind Sie sicher, dass Sie %USER_NAME% sperren möchten?
Dadurch werden Sie und %USER_NAME% nicht mehr in der Lage sein, Beiträge des jeweils anderen auf Investing.com zu sehen.
%USER_NAME% wurde erfolgreich zu Ihrer Sperrliste hinzugefügt.
Da Sie diese Person entsperrt haben, müssen Sie 48 Stunden warten, bevor Sie sie wieder sperren können.
Diesen Kommentar melden
Sagen Sie uns Ihre Meinung zu diesem Kommentar
Kommentar markiert
Vielen Dank!
Ihre Meldung wurde zur Überprüfung an unsere Moderatoren geschickt